XML 90 R30.htm IDEA: XBRL DOCUMENT v3.21.2
STOCK OPTION AND BENEFIT PLANS (Tables)
 12 Months Ended
Jul. 03, 2021
Share-based Payment Arrangement [Abstract]  
Grant Date Fair Value for Awards Estimated Using Option Valuation Method with Weighted Average Assumptions
On July 23, 2020, the Company granted 155,000 SARs under the 2010 Incentive Plan to certain key employees and outside directors at a strike price of $6.94 and a grant date fair value of $2.32. As of July 3, 2021, 150,000 remain outstanding. The grant date fair value for the awards granted during fiscal year 2021, were estimated using the Black Scholes option valuation method with the following weighted average assumptions as of July 23, 2020:
Fiscal Year 2021
 July 23, 2020
Expected dividend yield—%
Risk – free interest rate0.17%
Expected volatility42.85%
Expected life4.00
On July 26, 2019, the Company granted 175,000 SARs under the 2010 Incentive Plan to certain key employees and outside directors at a strike price of $4.93 and a grant date fair value of $1.23. As of July 3, 2021, 140,000 remain outstanding. The grant date fair value for the awards granted during fiscal year 2020, were estimated using the Black Scholes option valuation method with the following weighted average assumptions as of July 26, 2019:
Fiscal Year 2020
 July 26, 2019
Expected dividend yield—%
Risk – free interest rate1.54%
Expected volatility28.50%
Expected life4.00
On July 27, 2018, the Company granted 161,250 SARs under the 2010 Incentive Plan to certain key employees and outside directors at a strike price of $8.17 and a grant date fair value of $2.27. As of July 3, 2021, 116,250 remain outstanding. The grant date fair value for the awards granted during fiscal year 2019, were estimated using the Black Scholes option valuation method with the following weighted average assumptions as of July 27, 2018:
Fiscal Year 2019
 July 27, 2018
Expected dividend yield—%
Risk – free interest rate2.80%
Expected volatility29.75%
Expected life4.00
Summarizes Option/SARs Activity of All Plans
The following table summarizes the Company’s Options and SARs activity for all plans from July 1, 2018 through July 3, 2021:
 
SARs
Available
For Grant		SARs
Outstanding		Aggregate
Intrinsic
Value (in
thousands)		Weighted
Average
Exercise
Price		Weighted
Average
Remaining
Contractual
Life (in
years)
Balances, July 1, 2018404,335 1,074,999 $79 $8.90 2.3
Shares authorized— — 
SARs granted(161,250)161,250 8.17 
SARs forfeited250,833 (250,833)10.59 
SARs exercised— — — — 
Balances June 30, 2019493,918 985,416 $— $8.35 1.7
Shares authorized— — 
SARs granted(175,000)175,000 4.93 
SARs forfeited290,833 (290,833)7.71 
SARs exercised— — — — 
Balances, June 27, 2020609,751 869,583 $— $7.87 1.9
Shares authorized— — 
SARs granted(155,000)155,000 6.94 
SARs forfeited213,333 (213,333)9.88 
SARs exercised20,000 (20,000)— 7.72 
Balances, July 3, 2021688,084 791,250 $— $7.15 1.9
Exercisable at July 3, 2021385,000 $— $7.73 0.6
Additional Information Regarding Options Outstanding
Additional information regarding SARs outstanding and exercisable as of July 3, 2021, is as follows:
Range of
Exercise Prices		Number OutstandingWeighted Avg.
Remaining
Contractual Life (yrs.)		Weighted Avg.
Exercise Price		Number
Exercisable		Weighted
Avg. Exercise
Price
$4.40 – $7.90477,500 2.6$6.48 187,500 $7.26 
7.91 – 9.91313,750 0.38.17 197,500 8.17 
$4.40 to $11.34791,250 1.9$7.15 385,000 $7.73